Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Melanoma 8Uterine Cervical Neoplasms 2Skin Neoplasms 2Rectal Neoplasms 2Neoplasms 2Leukemia 2Colonic Neoplasms 2Breast Neoplasms 2Weight Loss 1Uveal Melanoma 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Testicular Neoplasms 1Spondylitis, Ankylosing 1Sarcoma 1Psychological Well-Being 1Psoriasis 1Pharyngeal Neoplasms 1Pancreatic Neoplasms 1Overweight 1Obesity 1Mouth Neoplasms 1Motor Activity 1Lymphoma, Non-Hodgkin 1Lymphoma 1Lupus Erythematosus, Systemic 1Liver Neoplasms 1Kidney Neoplasms 1Inflammatory Bowel Diseases 1Hodgkin Disease 1

Interventions

Standard of Care 1Practice Guidelines as Topic 1Methods 1Interviews as Topic 1Etanercept 1Educational Status 1Eating 1Early Intervention, Educational 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Psoriasis × Methods × Dermatologic × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡